Anas Younes Selected Research

Anas Younes Research Topics

Disease

103	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 01/2002
80	Neoplasms (Cancer) 10/2023 - 01/2002
74	Lymphoma (Lymphomas) 11/2023 - 12/2002
38	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 09/2003
28	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2023 - 11/2010
19	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2023 - 03/2003
17	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 08/2023 - 12/2003
16	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 08/2003
12	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 10/2016 - 12/2003
9	Neutropenia 10/2018 - 07/2005
8	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 02/2008
7	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2019 - 10/2004
6	Disease Progression 10/2018 - 03/2004
6	Infections 12/2017 - 04/2005
6	Necrosis 03/2011 - 08/2003
5	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 11/2015 - 05/2012
4	Febrile Neutropenia 12/2020 - 07/2005
4	Thrombocytopenia (Thrombopenia) 01/2018 - 11/2010
4	Leukemia 02/2012 - 10/2004
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2019 - 08/2008
3	Anemia 08/2017 - 07/2005
3	Multiple Myeloma 08/2017 - 03/2004
3	Nausea 08/2017 - 03/2015
2	Exanthema (Rash) 01/2022 - 02/2019
2	Hypertension (High Blood Pressure) 01/2022 - 08/2017

Drug/Important Bio-Agent (IBA)

35	Rituximab (Mabthera)FDA Link 01/2023 - 07/2003
31	Brentuximab VedotinIBA 01/2022 - 11/2010
25	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 12/2004
18	Monoclonal AntibodiesIBA 01/2023 - 03/2003
16	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2003
14	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 12/2004
13	ibrutinibIBA 01/2022 - 08/2014
12	Vincristine (Oncovin)FDA LinkGeneric 01/2023 - 12/2004
11	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 11/2006
11	Dacarbazine (DIC)FDA LinkGeneric 01/2022 - 11/2006
10	Prednisone (Sone)FDA LinkGeneric 01/2023 - 12/2004
10	Vinblastine (Vinblastine Sulfate)FDA Link 01/2022 - 11/2006
10	PanobinostatIBA 11/2018 - 09/2010
10	Histone Deacetylase InhibitorsIBA 11/2018 - 11/2009
9	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2012
9	LigandsIBA 10/2018 - 09/2003
9	Immunoconjugates (Immunoconjugate)IBA 01/2018 - 01/2007
8	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022 - 04/2005
8	CytokinesIBA 05/2014 - 08/2003
7	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 12/2002
7	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 12/2003
7	Bortezomib (Velcade)FDA Link 01/2018 - 05/2004
7	fludarabineIBA 01/2016 - 12/2002
6	mocetinostatIBA 01/2023 - 09/2010
6	NivolumabIBA 01/2021 - 01/2016
6	Etoposide (VP 16)FDA LinkGeneric 01/2018 - 04/2005
5	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 10/2013
5	Phosphotransferases (Kinase)IBA 01/2023 - 08/2004
5	AntigensIBA 01/2020 - 01/2007
5	Histone Deacetylases (Histone Deacetylase)IBA 01/2019 - 11/2009
5	AntibodiesIBA 01/2016 - 08/2005
5	Vorinostat FDA Link 07/2013 - 04/2008
5	tanespimycin (17AAG)IBA 05/2012 - 04/2005
5	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2007 - 04/2005
4	B7-H1 AntigenIBA 01/2023 - 02/2016
4	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022 - 08/2014
4	EnzymesIBA 11/2017 - 11/2009
4	Melphalan (Alkeran)FDA LinkGeneric 01/2016 - 04/2005
4	Gemcitabine FDA Link 01/2016 - 02/2008
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2008 - 08/2003
4	NF-kappa B (NF-kB)IBA 03/2007 - 01/2002
3	GalliumIBA 11/2023 - 06/2007
3	Immunoglobulins (Immunoglobulin)IBA 01/2023 - 01/2020
3	Bendamustine Hydrochloride FDA Link 12/2022 - 08/2017
3	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2021 - 08/2003
3	Pentostatin (Nipent)FDA LinkGeneric 01/2019 - 09/2003
3	Antisense OligonucleotidesIBA 11/2018 - 11/2008
3	Carboplatin (JM8)FDA LinkGeneric 01/2018 - 03/2015
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2018 - 02/2006
3	CUDC-907IBA 11/2017 - 01/2016
3	entinostat (MS 275)IBA 01/2016 - 09/2010
3	Protein Isoforms (Isoforms)IBA 01/2016 - 10/2011
3	Paclitaxel (Taxol)FDA LinkGeneric 10/2014 - 03/2006
3	InterferonsIBA 05/2012 - 07/2005
3	MTOR InhibitorsIBA 04/2012 - 07/2008
3	temsirolimus FDA Link 11/2010 - 04/2008
3	TOR Serine-Threonine KinasesIBA 11/2010 - 04/2008
3	Proteasome InhibitorsIBA 11/2010 - 05/2004
3	galiximabIBA 01/2007 - 03/2003
2	Heme (Haem)IBA 10/2023 - 12/2018
2	Lenalidomide (CC 5013)FDA Link 08/2023 - 07/2012
2	venetoclaxIBA 01/2023 - 01/2021
2	atezolizumabIBA 01/2023 - 10/2022
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 06/2003
2	NVP-BKM120IBA 01/2022 - 12/2017

Therapy/Procedure

77	Therapeutics 08/2023 - 12/2002
42	Drug Therapy (Chemotherapy) 10/2021 - 03/2002
23	Stem Cell Transplantation 01/2018 - 12/2002
8	Radiotherapy 10/2022 - 03/2002
5	Combination Drug Therapy (Combination Chemotherapy) 07/2016 - 09/2003
4	Immunotherapy 01/2021 - 02/2008
4	Aftercare (After-Treatment) 12/2013 - 07/2005
3	Drug Tapering 12/2020 - 05/2012
3	Precision Medicine 11/2019 - 10/2014
3	Salvage Therapy 01/2018 - 11/2014